The Journal of clinical endocrinology and metabolism, cilt.104, sa.7, ss.2527-2534, 2019 (SCI-Expanded)
Context: Dopamine agonist (DA)-induced impulse control disorder (ICD) in patients with prolactinomas is not sufficiently known.